SMTL ID : 3wig.2 (1 other biounit)

Human MEK1 kinase in complex with CH5126766 and MgAMP-PNP

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

homo-dimer

Ligands

2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)

ANP.1: 18 residues within 4Å: Chain A: L.14, G.15, A.16, G.17, V.22, A.35, K.37, E.84, H.85, M.86, S.90, Q.93, K.132, S.134, N.135, L.137, D.148 Ligands: MG.2 9 PLIP interactions: 9 interactions with chain A Hydrogen bonds: A:E.84, A:H.85, A:M.86, A:S.90, A:S.90, A:S.90, A:K.132, A:S.134 Salt bridges: A:K.37 ANP.10: 18 residues within 4Å: Chain B: L.14, G.15, A.16, G.17, V.22, A.35, K.37, E.84, H.85, M.86, S.90, Q.93, K.132, S.134, N.135, L.137, D.148 Ligands: MG.11 9 PLIP interactions: 9 interactions with chain B Hydrogen bonds: B:E.84, B:M.86, B:S.90, B:S.90, B:S.90, B:K.132, B:S.134, B:D.148 Salt bridges: B:K.37

2 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain A: K.37, N.135, D.148 Ligands: ANP.1 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:D.148 MG.11: 4 residues within 4Å: Chain B: K.37, N.135, D.148 Ligands: ANP.10 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:D.148

2 x CHU: N-(3-fluoro-4-{[4-methyl-2-oxo-7-(pyrimidin-2-yloxy)-2H-chromen-3-yl]methyl}pyridin-2-yl)-N'-methylsulfuric diamide(Non-covalent)

CHU.3: 21 residues within 4Å: Chain A: L.55, L.58, V.67, G.68, F.69, I.81, M.83, H.128, R.129, D.130, C.147, D.148, F.149, G.150, V.151, S.152, L.155, I.156, M.159, N.161, S.162 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.58, A:V.67, A:I.81, A:F.149, A:L.155, A:L.155, A:I.156 Hydrogen bonds: A:R.129, A:D.148, A:V.151, A:S.152, A:N.161, A:S.162 Water bridges: A:N.161 CHU.12: 21 residues within 4Å: Chain B: L.55, L.58, V.67, G.68, F.69, I.81, M.83, H.128, R.129, D.130, C.147, D.148, F.149, G.150, V.151, S.152, L.155, I.156, M.159, N.161, S.162 14 PLIP interactions: 14 interactions with chain B Hydrophobic interactions: B:L.58, B:V.67, B:I.81, B:F.149, B:L.155, B:L.155, B:I.156 Hydrogen bonds: B:R.129, B:D.148, B:V.151, B:S.152, B:N.161, B:S.162 Water bridges: B:N.161

2 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)

PG4.4: 9 residues within 4Å: Chain A: K.125, G.150, V.151, G.153, I.156 Chain B: G.153, Q.154, D.157 Ligands: PG4.13 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:G.153, B:G.153 PG4.13: 9 residues within 4Å: Chain A: G.153, Q.154, D.157 Chain B: K.125, G.150, V.151, G.153, I.156 Ligands: PG4.4 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:G.153, B:G.153

10 x CL: CHLORIDE ION(Non-functional Binders)

CL.5: 3 residues within 4Å: Chain A: R.121, S.181, V.182 Ligand excluded by PLIP CL.6: 2 residues within 4Å: Chain A: T.166, R.167 Ligand excluded by PLIP CL.7: 2 residues within 4Å: Chain A: F.279, A.280 Ligand excluded by PLIP CL.8: 2 residues within 4Å: Chain A: S.239, L.240 Ligand excluded by PLIP CL.9: 2 residues within 4Å: Chain A: E.42 Chain B: H.179 Ligand excluded by PLIP CL.14: 3 residues within 4Å: Chain B: R.121, S.181, V.182 Ligand excluded by PLIP CL.15: 2 residues within 4Å: Chain B: T.166, R.167 Ligand excluded by PLIP CL.16: 2 residues within 4Å: Chain B: F.279, A.280 Ligand excluded by PLIP CL.17: 2 residues within 4Å: Chain B: S.239, L.240 Ligand excluded by PLIP CL.18: 2 residues within 4Å: Chain A: H.179 Chain B: E.42 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lito, P. et al., Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors. Cancer Cell (2014)

Release Date

2014-06-04

Peptides

Dual specificity mitogen-activated protein kinase kinase 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Dual specificity mitogen-activated protein kinase kinase 1

Related Entries With Identical Sequence